James Sigg is the Food and Drug Administration's (FDA) Chief Operating Officer, a position he held previously from January to April of 2012. In this role, he maintains oversight of FDA’s information technology, ethics, equal employment opportunity, human resources, safety and security, facilities, acquisition, and financial management programs for the agency world-wide.
Mr. Sigg has been with the FDA for 24 years, most recently serving as the Associate Director for Management, Executive Officer, and Director of the Office of Management in the Center for Biologics Evaluation and Research’s (CBER) since 2008. In these roles, he managed CBER’s annual budget of $300 million and provided executive leadership in the areas of workforce development, budget formulation and execution, resource management, program planning and evaluation, and other administrative services that support CBER’s public health mission. Mr. Sigg advised CBER’s Director and senior executives on Center-wide administrative functions including financial management, human resources, and procurement. Under his leadership, he strategically managed the move of over 1,100 employees and contractors, 70 laboratories and approximately 14,000 research animals from eight locations to the FDA White Oak Campus with no disruption to critical regulatory and administrative operations.
Throughout his tenure at FDA, Mr. Sigg has held various positions within CBER, including Contract Liaison Officer, Special Assistant to the Director of the Office of Management, and Deputy Director of the Office of Management.
Mr. Sigg earned a B.S. in Business Management from Saint Francis College. He has been the recipient of three Commissioner’s Special Citation awards for his contributions in leading improvements in human resources efforts. He also received the FDA Award of Merit in 2013 for his extraordinary leadership in managing fiscal responsibilities and staffing.